Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. With Druggability Technologies
enter to search
Our vision is to transform drug development with science and innovation
We are a dedicated team passionate about innovating and transforming drug development
Quotient Sciences operates from state-of-the-art manufacturing and clinical facilities in the U.S. and U.K.
Meet our board of directors
Discover our global locations
Discover how pharmaceutical and biotechnology organizations have achieved success using our services
Learn more about our stand-alone services and integrated solutions
Explore our wide range of conference posters and presentation slides
Learn how we can help you transform your drug development with science and innovation
GDC-0810, administered orally, was used in Phase I and II clinical studies to treat estrogen receptor positive breast cancers.
Clinical trial manufacturing
Ask us a question